Brind.

Aging population is driving increased demand for medical treatments from companies like AbbVie, Amgen, and Dexcom.

2 reports, 2 independent Updated Sep 2

Gone quiet Reached 2 outlets in its first 24 hours

Reports: 2
Developments: 1
Repetition: 50%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Aging population is driving increased demand for medical treatments from companies like AbbVie, Amgen, and Dexcom.

Who's involved

What this event is mainly about

AbbVie Amgen Dexcom

Keep exploring

The entities involved

AbbVie
pharmaceutical company
- MarketBeat's screener has identified a list of dividend stocks.Sun 22:22
- AbbVie's product portfolio was bolstered by the acquisition of Allergan, while Humira sales faced erosion due to patent loss and biosimilar competition.Sun 13:48
Amgen
American multinational biopharmaceutical company
- Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
- Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
Dexcom
company that develops, manufactures and distributes continuous glucose monitoring systems
- Tandem Mobi utilizes Dexcom G7 technology for monitoring.Mon 09:18

Coverage

Newest first; wire copies grouped

Sep 2ZacksInvesting in the Age of Longevity: Silver Economy Stocks in Focus An updated edition of the July 11, 2025 article. The world’s population is aging fast, reshaping the way healthcare systems, investor
Aug 27StockStorySpotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q2 Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - spe